Brief: Noxopharm Announces Darrt-2 Clinical Trial In U.S.
09/11/2021 13:42
Nov 9 (Reuters) - Noxopharm Ltd NOX.AX :
* NOXOPHARM ANNOUNCES DARRT-2 CLINICAL TRIAL IN U.S.
Source text for Eikon: ID:nBwSgTnYa
Further company coverage: NOX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsAustralia's Noxopharm hits three-month low on discounted placement
Brief: Noxopharm Receives Commitments For Placement
Brief: Noxopharm Requests Trading Halt Pending Material Capital Raising Announcement
Brief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential